Biological messengers can be "caged" by adding a single photosensitive group that can be photolyzed by a light flash to achieve spatially and temporally precise biochemical control. Here we report that photolysis of a double-caged form of the second messenger inositol 1,4,5-trisphosphate (IP 3 ) triggers focal calcium release in Purkinje cell somata, dendrites, and spines as measured by two-photon microscopy. In calbindin knock-out Purkinje cells, peak calcium increased with flash energy with higher cooperativity for double-caged IP 3 than for conventional single-caged IP 3 , consistent with a chemical twophoton effect. Spine photolysis of double-caged IP 3 led to local calcium release. Uncaging of glycerophosphoryl-myo-inositol 4,5-bisphosphate (gPIP 2 ), a poorly metabolizable IP 3 analog, led to less well localized release. Thus, IP 3 breakdown is necessary for spine-specificity. IP 3 -and gPIP 2 -evoked signals declined from peak with similar, slow time courses, indicating that release lasts hundreds of milliseconds and is terminated not by IP 3 degradation but by intrinsic receptor dynamics. Based on measurements of spine-dendrite coupling, IP 3 -evoked calcium signals are expected to be at least 2.4-fold larger in their spine of origin than in nearby spines, allowing IP 3 to act as a synapsespecific second messenger. Unexpectedly, single-caged IP 3 led to less release in somata and was ineffective in dendrites and spines. Calcium release using caged gPIP 2 was inhibited by the addition of single-caged IP 3 , suggesting that single-caged IP 3 is an antagonist of calcium release. Caging at multiple sites may be an effective general approach to reducing residual receptor interaction.
Inositol 1,4,5-trisphosphate binds to receptors on internal organelles, triggering calcium (Ca 2ϩ ) release from stores and thus elevating cytoplasmic calcium concentration. Calcium elevation can trigger a wide variety of physiological responses in many cell types (1) . In neurons, inositol 1,4,5-trisphosphate (IP 3 )-triggered calcium release can be extremely rapid, beginning considerably less than 100 ms after synaptic activity (2) (3) (4) . Such a rapid response implies that IP 3 2 is produced within 10s of ms of receptor activation. Furthermore, calcium release mechanisms nearly always have strong inactivation mechanisms that can depend on recent activation. Therefore, the rapid kinetics of IP 3 concentration and receptor dynamics are key determinants of the properties of calcium release.
The properties of IP 3 -dependent calcium release may guide the properties of synaptic plasticity. In cerebellar Purkinje cells, which strongly express IP 3 receptors, IP 3 receptor-mediated calcium release is necessary for the induction of long-term depression of parallel fiber synapses (5, 6) . Calcium release in dendritic spines is thought to act as a coincidence detector between parallel fiber activity, which generates IP 3 , and climbing fiber activity, which causes calcium entry that boosts release by acting on the IP 3 receptor (4, 7) . In this model the duration of IP 3 receptor activation should shape the timing conditions under which parallel fiber and climbing fiber activity are able to work together to generate maximal calcium release. Probing IP 3 receptor dynamics in spines in situ would provide strong constraints to the model.
A critical advance in understanding calcium signaling responses to fast patterns of IP 3 production has come as a result of the development of caged compounds (8 -10) . Caged compounds are signaling molecules rendered biologically inactive by the addition of a light-sensitive group. Upon absorption of a photon in the near ultraviolet, the caged compound undergoes internal photolysis, cleaving the cage group and generating active molecules. When the light comes in the form of a flash, the production of messenger is rapid, and with a focused beam such as from a laser, submicron spatial resolution is possible.
In the case of IP 3 , the standard caging approach has been to add a 1-(2-nitrophenyl)ethyl (NPE) group at the 4 or 5 position (11) . "Single-caged" IP 3 produced in this way does not activate IP 3 receptors, photolyses in milliseconds, and largely does not interfere with IP 3 metabolism by kinases and phosphatases (though in the case of 5-NPE-IP 3 see (12) ). Single-caged IP 3 has been successfully applied to the study of signaling in smooth muscle (13) , cell nuclei (14, 15) , neurons (3, 5, 6, 16, 17) , and astrocytes (18).
As a means of controlling calcium release in neurons, we made double-caged IP 3 , a form that is caged at both the 4 and 5 positions. This compound is structurally less similar than single-caged IP 3 to IP 3 and, therefore, should be less likely to interfere with IP 3 receptors or degradative enzymes. In addition, double-caged compounds allow an approach, termed chemical two-photon uncaging, that has several advantages. First, the requirement for removing two cage groups gives positive cooperativity, and therefore, in response to focused flashes, spatial resolution in both lateral and axial directions is improved (19) . Second, because each molecule bears two cage groups, small amounts of uncaging that occur during routine handling or after solvation in water produce lower levels of residual IP 3 .
In this study we report the first use of double-caged IP 3 in the study of intracellular calcium release. We find that in cerebellar Purkinje neurons, double-caged IP 3 is more potent than singlecaged IP 3 in triggering flash-induced calcium release. In addition, double-caged IP 3 can activate release in dendritic locations remote from the cell body, but single-caged IP 3 cannot. These phenomena can be explained by a blocking action by single-caged IP 3 on calcium release. The improved effectiveness of double-caged IP 3 makes it the preferred reagent for rapid control over IP 3 -dependent calcium release in neurons. Finally, we use double-caged IP 3 to probe the synapse specificity of calcium release in single dendritic spines. 3 Compounds-Synthesis of caged compounds was done under incandescent light. Five mg of IP 3 (M r 551.99, LC Laboratories, Woburn, MA) was dissolved in 500 l of H 2 O, and the pH was adjusted to 4.5 with HCl. 1-(Nitrophenyl)-diazoethane was prepared by mixing 0.18 g of the hydrazone of 2-nitrosoacetophenone with 0.7 g of MnO 2 in 20 ml of ether, mixing vigorously for 5-10 min, and filtering the mixture. IP 3 was pipetted into the 1-(2-nitrophenyl)-diazoethane. The volume was reduced by blowing compressed nitrogen over the mixture, which was then covered with glass wool and mixed vigorously overnight. Unreacted 1-(2-nitrophenyl)-diazoethane was extracted with methylene chloride.
MATERIALS AND METHODS

Preparation of Caged IP
Caged compounds were purified by high performance liquid chromatography on a Partisil 10 SAX column (initial condition 0.12 M NH 4 H 2 PO 4 /NH 4 HPO 4 , pH 5.4, 30% methanol) (12) . The sample was injected, and after 5 min, a 15-min linear gradient was begun to a final condition of 0.6 M NH 4 H 2 PO 4 /NH 4 HPO 4 , pH 5.4, 30% methanol. The column was monitored by absorption at 260 nm. The peak at 5-7 min was taken as triple-NPEcaged IP 3 .
Triple-caged IP 3 was photolyzed 6 ϫ 30 s with a handheld ultraviolet lamp. Fractions were collected with the following migration times: 5-7 min, triple-caged IP 3 , 1,4-double-caged IP 3 , and 1,5-double-caged IP 3 ; 8 -10 min, 4,5-double-caged IP 3 ; 14 -15 min, 5-caged IP 3 ; 15-16 min, 4-caged IP 3 ; 16 -17 min, 1-caged IP 3 . Fractions from multiple runs were pooled, and the high performance liquid chromatography solvent was then removed using a DEAE-cellulose column at 4°C. Caged IP 3 compounds were eluted with a linear gradient of 0 -0.5 M tetraethylammonium bicarbonate (TEAB) more than 100 min. TEAB was removed by rotary evaporation under vacuum. The compound was resuspended in distilled water and stored at Ϫ20°C.
Slice Preparation-Sagittal 300-m-thick cerebellar brain slices were cut from 17-21-day-old rats or 2-3-month-old calbindin knock-out mice (strain B6.129-Calb1 tm1Mpin /J; The Jackson Laboratory, Bar Harbor, ME) in ice-cold artificial cerebrospinal fluid containing 126 mM NaCl, 3 mM KCl, 1 mM NaH 2 PO 4 , 20 mM D-glucose, 25 mM NaHCO 3 , 2 mM CaCl 2 , and 1 mM MgCl 2 and saturated with 95% O 2 , 5% CO 2 . Slices were preincubated at 34°C for 40 -60 min and then kept at room temperature throughout the experiment.
Electrophysiology-For recording, slices were transferred to an immersion-type recording chamber perfused at 2-4 ml/min with artificial cerebrospinal fluid solution saturated with 95% O 2 , 5% CO 2 . Purkinje cells were visually patched with recording electrodes pulled from 1-mm borosilicate glass to a resistance of 4 -7 megaohms. Electrophysiological signals were acquired with an Axopatch 200B amplifier and Clampex 8.0 software (Axon Instruments, Foster City, CA). The patch electrode was filled with a patch solution containing (pH was adjusted to 7.3 with KOH) 133 mM methanesulfonic acid, 7.4 mM KCl, 0.3 mM MgCl 2 , 3 mM Na 2 ATP, and 0.3 mM Na 3 GTP along with 300 M calcium indicator fluo-5F (Invitrogen) and one of the following caged compounds: 5-caged IP 3 , a mixture of 4-and 5-caged IP 3 , 4,5-double-caged IP 3 , caged glycerophosphoryl-myo-inositol 4,5-bisphosphate (gPIP 2 ), or commercially obtained singlecaged IP 3 (Invitrogen), which is a mixture of 4 and 5 isomers. In some experiments aurintricarboxylic acid, ammonium salt (ATA; Sigma) was used to block IP 3 breakdown. After wholecell break-in, cells were held in current clamp mode for at least 40 min to allow diffusion of the dye and caged compound to the distal dendrites and spines. Holding currents at Ϫ65 mV were Ϫ50 to Ϫ400 pA, and series resistances were 20 -30 megaohms. Series resistance was monitored periodically and compensated by balancing the bridge.
Two-photon Microscopy and Focal Uncaging-Two-photon fluorescence imaging was done using a custom-built microscope controlled by CfNT software (M. Müller, Max Planck Institute for Medical Research, Heidelberg, Germany). 830-nm excitation light from a Mira 900 Ti:sapphire laser (Coherent Inc., Auburn, CA) was focused onto the brain slice by 63ϫ 0.9 NA water immersion objective (Carl Zeiss, Thornwood, NY). For focal uncaging (20) the output of a UV laser (DPSS Lasers, Santa Clara, CA) was attenuated by a polarizing beam splitter, widened by a 5ϫ beam expander (CVI Laser Corp., Albuquerque, NM) to fill the back aperture of the objective, and merged with the excitation beam using a dichroic mirror (Omega Optical, Brattleboro, VT). To compensate for the focal plane shift between uncaging and excitation light, the uncaging beam was slightly converged by adjusting the beam expander. The parfocality of the uncaging spot and the image plane was tested by uncaging in a sample of caged fluorescein dextran solution dried onto a test slide. Flash energies were calculated from energies arriving at the backplane of the objective multiplied by the 70% transmittance of the objective. For focal uncaging in different cell regions, a procedure was usually employed in which uncaging was attempted first in the soma or main dendrites. If measurable responses were observed in these structures, then uncaging attempts were made in fine spiny branchlets and single spines. In some double-caged IP 3 experiments, uncaging was done only in spiny branchlets and spines.
Data Analysis-Full-frame images were acquired at a speed of 5 ms per line (512 pixels/line) or 2 ms per line (128 pixels/ line). Fluorescence data were processed using Igor Pro software (Wavemetrics, Lake Oswego, OR). ⌬F/F 0 traces were filtered by convolving with a hanning window of width 5 samples (Figs. 2 and 5) or 11 samples (Fig. 4) . Peak fluorescence was defined as the maximum value after 11-sample filtering. Response area was integrated over 200 ms after the UV flash. The initial response slope was defined as the slope of the linear fit between 15 and 85% of peak response. The response latency was defined as ending when the unfiltered trace went more than 1.5 S.D. above preflash baseline for three consecutive samples, taking the middle of the three samples. For purposes of scoring uncaging trials, a successful trial was defined as one that triggered a peak fluorescence change of 50%⌬F/F 0 or greater. For measuring the dependence of response size on flash energy (Fig. 2) , curves for individual locations were normalized by flash energy to minimize the uncertainty of a power fit to pooled data. Except where otherwise indicated, all statistical comparisons are one-tailed tests.
Calculation of IP 3 Photolysis-The efficiency of IP 3 generation was calculated using the inverse relationship between latency and IP 3 concentration (21) . The availability of multiple measurements using single-caged IP 3 was used to calculate the uncertainty in overall fits and in IP 3 concentration. With 100 M single-caged IP 3 in the pipette and uncaging in the soma, calcium response latencies were measured in response to varying pulse energies. IP 3 concentration would be expected to increase with pulse energy P as (IP 3 
), where C is the concentration of single-caged IP 3 , and g is the energy to photolyze 1 Ϫ 1/e of the cage groups. g was varied to determine a best fit for [IP 3 ] to single-caged IP 3 latency data. The resulting uncaging efficiency factor was g ϭ 0.59 Ϯ 0.07 J over a range of pulse energies of 0.3-1.0 J. This calibration was then applied to double-caged IP 3 experiments to calculate the IP 3 concentration as [IP 3 
RESULTS
The caged compounds used in this study are shown in Fig. 1a , in which modifications to the phosphate groups at positions 1, 4, and 5 are indicated as R 1 , R 2 , and R 3 , respectively. The 4,5-biphosphate motif has been found to be necessary for IP 3 receptor activation (12, 22) , and modification at the 1-position has been shown to moderately affect the potency of receptor activation and strongly inhibit metabolism by 3-kinases and 5-phosphatases (23) . IP 3 caged with NPE groups at either the 4 or 5 position (singlecaged IP 3 ) was synthesized or obtained commercially as a mixture of the two isomers. NPE-caged glycerophosphoryl-myo-inositol 4,5-bisphosphate (caged-gPIP 2 ) (23) was obtained commercially. IP 3 caged with NPE groups at both the both the 4 and 5 positions ("double-caged IP 3 ") was synthesized by preparation of triple-caged IP 3 followed by partial photolysis. Photolysis and measurement of calcium release was performed on a system (Fig. 1b) in which an ultraviolet laser beam was directed into the focal plane of a two-photon microscope and a brain slice chamber (Fig. 1c) , thus achieving submicron resolution of both uncaging and fluorescence measurement (average halfmaximal width of fluorescent spot after uncaging ϭ 0.59 m; Fig. 1d ).
To test the ability of double-caged IP 3 to trigger calcium release, we recorded from Purkinje neurons, which express IP 3 receptors at extremely high density (24) , using whole-cell patch recording. Patch electrodes contained 100 M double-caged IP 3 with 300 M fluo-5F added to monitor changes in cytoplasmic calcium. Under these conditions all parts of the cell, including dendrites and spines, were visible ( Fig. 1c) , indicating perfusion with patch solution. In observations of the cell body by twophoton fluorescence microscopy ( Fig. 2a) , light pulses (0.13-1.0 J) generated reproducible sudden elevations in calcium that began 10 -100 ms after the pulse (15 locations in 10 cells). Maximum responses were 600 Ϯ 250 (mean Ϯ S.D.) % ⌬F/F 0 above baseline fluorescence (n ϭ 7, 1 cell body and 6 dendrites). Thus photolysis of double-caged IP 3 can trigger robust calcium release signals in Purkinje neurons.
In previous studies using conventional single-caged IP 3 , the kinetics of photolysis-driven calcium release were shown to depend strongly on IP 3 concentration (21). We found likewise that photolyzing increasing amounts of double-caged IP 3 triggered progressively faster-rising and larger calcium transients ( peak of response), and 0.24 Ϯ 0.03 J (mean Ϯ S.D., for halfmaximal total area of response integrated over time; n ϭ 2 locations in 1 primary dendrite and 1 cell body).
Because two photolysis events at a double-caged IP 3 molecule are required to generate one molecule of IP 3 , the dependence of the amount of calcium released on flash energy would be expected to show more cooperativity (19) for double-caged IP 3 than for single-caged IP 3 . However, in wild-type rats, for a range of flash energies up to saturating levels, only a weak difference was observed (Fig. 2c) (25, 26) . In particular, calbindin has fast binding kinetics and can suppress submicromolar fast-rising calcium transients but not larger ones, thus leading to positive cooperativity at a step downstream of calcium mobilization (27) . This effect would tend to be independent of and, thus, mask any differences between the observed flash energy dependence of single-caged and double-caged responses. Such an effect would not be expected of parvalbumin, whose binding on-kinetics are entirely slow (28) . We therefore made comparisons between single-caged and double-caged IP 3 in knock-out mice lacking calbindin (Figs. 2, d and e) .
In calbindin knock-out mice differences between double-caged IP 3 and single-caged IP 3 were seen in the dependence of both the total area of response ( Fig. 2d ; log-log slope 3.08 Ϯ 0.19 in double-caged IP 3 versus 1.40 Ϯ 0.11 in single-caged IP 3 ; ratio of slopes ϭ 2.20 Ϯ 0.22, greater than 1, p Ͻ 0.01, two-tailed test) and the peak of fluorescence signal ( Fig. 2e ; log-log slope 1.22 Ϯ 0.14 in singlecaged IP 3 , 34 responses at 5 locations in 1 cell, normalized to saturated peak responses of 340 Ϯ 70% ⌬F/F 0 ; 2.75 Ϯ 0.23 in double-caged IP 3 , 47 responses at 5 locations in 1 cell, normalized to saturated peak responses of 350 Ϯ 40% ⌬F/F 0 ; ratio of slopes ϭ 2.26 Ϯ 0.31, greater than 1, p Ͻ 0.01, two-tailed test) on flash energy. The ratios of slopes are indistinguishable from 2 (p ϭ 0.32 for peak response and p ϭ 0.36 for area), consistent with the expectation that physiological effects produced by chemical two-photon uncaging should have a dependence on flash energy that is the square of the dependence seen with conventional uncaging (19) . IP 3 receptors are expressed abundantly throughout Purkinje cells, including dendrites and dendritic spines (24) . Because calcium release is necessary for inducing synaptic long-term depression at synaptic inputs impinging on spiny dendrites (3-5), we tested the ability of single-caged IP 3 and doublecaged IP 3 to trigger calcium release in dendrites and single spines ( Fig. 3 and Table 1 ). We performed uncaging in 12 cells filled with 100 M single-caged IP 3 , 7 cells filled with 300 M single-caged IP 3 , and 78 cells filled with 100 M double-caged IP 3 . A successful uncaging response was defined as one in which the peak fluorescence exceeded 50%⌬F/F 0 . We successfully evoked calcium responses in at least one location (soma, dendrite, or spine) in 92% of cells (11 of 12) filled with 100 M single-caged IP 3 , 86% of cells (6 of 7) filled with 300 M singlecaged IP 3 , and 99% of cells (77 of 78) filled with 100 M doublecaged IP 3 .
Uncaging at locations away from the cell body revealed a strong contrast between single-caged IP 3 and double-caged IP 3 . In dendrites (including all except for spiny branchlets), 100 M double-caged IP 3 was still effective at inducing calcium release (84%, 79 successes of 94 locations at which uncaging was done in 45 cells). However, 100 M single-caged IP 3 was considerably less successful (42%, 20 of 48 locations, 12 cells, different from double-caged IP 3 , p Ͻ 0.01, Fisher exact test). The response rate was once again high in recordings in which the concentration of single-caged IP 3 was 300 M (72%, 13 of 18 locations, 7 cells). Thus, in the main dendrites a deficit in calcium release by single-caged IP 3 can be overcome by increasing the concentration of caged compound used.
The difficulty of evoking calcium responses with singlecaged IP 3 reached extremes in the terminal spiny branchlets that give rise to the postsynaptic spines to parallel fibers (Fig. 3) . In spiny branchlets, 100 M double-caged IP 3 3 . Finally, in spines, using double-caged IP 3 we still had a high success rate, 74% (89 of 120 spines attempted, 37 cells), whereas 100 or 300 M single caged IP 3 again failed (0%, 0 of 6 spines attempted, 4 cells). Thus, in fine branchlets of the dendritic arbor, single-caged IP 3 was considerably less effective at triggering calcium release than double-caged IP 3 , and in dendritic spines it failed completely.
Calcium release by single-caged IP 3 could be blocked by a contaminant such as IP 3 itself, which can block release via usedependent inactivation (29) . However, in dendrites 100 M single-caged IP 3 was not effective whether it came from Invitrogen (2 successes of 13 locations) or was synthesized by us (mixed isomers, 1 success of 4 locations; 5-caged IP 3 , 12 successes of 22 locations). This is consistent with a previous finding that low concentrations (1 M) of IP 3 do not block Purkinje cell responses to single-caged IP 3 . 3 These findings suggest that the lack of calcium release in single-caged IP 3 experiments derives from the caged compound itself and not an impurity.
The failure of photolysis of single-caged IP 3 to trigger calcium release in the dendritic arbor raises the possibility that single-caged IP 3 itself might interfere with calcium release. Based on structure-function analysis (30), the agonist binding pocket of the IP 3 receptor interacts with all three phosphate groups of IP 3 . Screening of derivatives of IP 3 indicates that alterations of the 1-phosphate affects binding affinity to the receptor (31), whereas alterations of the 4,5-diphosphate function affect both affinity (32) and agonist activity (22, 33) . Thus single-caged IP 3 , which has either exposed 1-and 4-phosphates or exposed 1-and 5-phosphates, might act as a competitive antagonist to the IP 3 receptor. This hypothesis predicts that caged gPIP 2 , which bears only one unmodified phosphate, would allow calcium release.
We found that in Purkinje cells loaded with 300 M caged gPIP 2 , uncaging in dendrites and spines led to robust calcium release ( Fig. 3d and Table 1 ). Photolysis of caged gPIP 2 could evoke large calcium responses in the cell body, main dendrite, distal spiny dendrites, and spines (Fig. 4a) . To further test 3 K. Khodakhah, personal communication. whether single-caged IP 3 could antagonize calcium release, we measured its ability to interfere with the action of caged gPIP 2 . We compared responses in cells filled with 300 M caged gPIP 2 with cells filled with 300 M gPIP 2 plus 300 M single-caged IP 3 .
In the additional presence of 300 M single-caged IP 3 , responses were considerably smaller in small structures, with calcium release occurring only in large dendrites close to the cell body (Fig. 4b) , reminiscent of the single-caged IP 3 experiments. At the farthest points of the dendritic arbor tested, calcium release was entirely absent. For flashes of light that saturated calcium responsiveness, the response size varied as a function of distance from the soma (Fig. 4c) . Although photolysis of the gPIP 2 /single-caged IP 3 mixture evoked calcium signals only up to 70 m away from the cell body, uncaging of 300 M caged gPIP 2 alone successfully evoked calcium release in all structures regardless of distance from the soma. Calcium responses to uncaging over the cell body, main dendrite, spiny dendrites, and spines are plotted in Fig. 4d . On average, responses in cells filled with caged gPIP 2 / single-caged IP 3 mixture were smaller than responses in cells filled with caged gPIP 2 alone in every part of the soma and dendrites. Even the addition of a smaller amount of singlecaged IP 3 , 100 M, did not lead to larger calcium signals (Fig. 4c,   asterisks) despite the fact that IP 3 is a 10-fold more potent agonist than gPIP 2 (23) . Taken together, these observations demonstrate that high micromolar levels of single-caged IP 3 impair calcium release by other compounds.
We next wanted to quantify the antagonist activity of single-caged IP 3 by using the latency to first calcium rise, a distinctive kinetic signature of IP 3 -dependent calcium release. To determine the amount of IP 3 produced we used the inverse relationship between the latency to first calcium rise and IP 3 concentration (Fig. 5, a and b) (21) . This allowed us to use observations using single-caged IP 3 to calibrate the uncaging efficiency of our system and then use the calibration to calculate the amount of IP 3 produced from uncaging double-caged IP 3 . From previous measurements (21) the relationship between latency and IP 3 is parametrized by the latency- [IP 3 ] product, 875 Ϯ 85 ms-M. In our experiments latencies were well fitted to this relationship using an uncaging efficiency factor of g ϭ 0.59 Ϯ 0.07 J. This calibration was then applied to double-caged IP 3 experiments (Fig. 5c ) to calculate the IP 3 concentration. Latencies using double-caged IP 3 were 9.5 Ϯ 1.7 ms shorter than expected (mean Ϯ S.E., n ϭ 9 flash energies) ms (Fig. 5, d and e) . When expressed as the ratio of expected latency to observed latency, a similar discrepancy was seen across a range of flash energies and IP 3 concentrations (Fig. 5f) , with an average latency ratio of 1.41 Ϯ 0.08 (mean Ϯ S.E., n ϭ 9 flash energies).
We next used double-caged IP 3 and caged gPIP 2 to investigate the properties of calcium release in spiny branchlets and single spines. When IP 3 or gPIP 2 is uncaged locally, the resulting calcium transient should be determined by the time course of local IP 3 receptor activation and the diffusion and removal of released calcium. For comparison we measured the time course of climbing fiber-evoked signals (Fig. 6a) in which calcium enters during a pan-dendritic action potential lasting only ϳ10 ms (34) . Climbing fiber-evoked spine signals peaked within 8 -12 ms and fell to half of the peak value in less than 100 ms. IP 3 -evoked spine signals rose more slowly and had a more prolonged decline (Fig.  6a, bottom) . In this example the time course of the IP 3 -evoked release signal was similar to a convolution of the climbing fiber response with a flux kernel 180 ms long (Fig. 6a, bottom) .
To quantify the approximate duration of flash-evoked calcium release, we measured the time after a stimulus for the fluorescence to rise and then fall to half of its peak value ( 6b). For climbing fiber-evoked action potentials this interval was 77 Ϯ 5 ms (mean Ϯ S.E., n ϭ 65) in dendrites and 56 Ϯ 2 ms (mean Ϯ S.E., n ϭ 80) in spines. For IP 3 (signals smaller than 400% ⌬F/F 0 ) the time from flash to half-fall was significantly longer than action potential-evoked signals both in dendrites (244 Ϯ 10 ms, mean Ϯ S.E., n ϭ 54, p Ͻ 0.001) and in spines (305 Ϯ 16 ms, mean Ϯ S.E., n ϭ 27, p Ͻ 0.001). The time to half-fall of gPIP 2 -evoked transients (smaller than 400% ⌬F/F 0 ) was also longer (in dendrites, 191 Ϯ 11 ms, mean Ϯ S.E., n ϭ 46, p Ͻ 0.001; in spines, 255 Ϯ 22 ms, mean Ϯ S.E., n ϭ 10, p Ͻ 0.001). These times are longer not only than the time course of action potential-mediated signals but also longer than typical diffusion times from a micron-scale source, which would be expected to be on the order of 10s of ms (35) . Thus, both agonists lead to flux through calcium release channels that can last for several hundred milliseconds.
The time course of receptor activation could potentially be shaped in part by degradation of IP 3 . If this were true, then gPIP 2 , which is degraded more slowly than IP 3 , would be expected to trigger longer-lasting calcium signals than IP 3 . The time from flash to half-fall of gPIP 2 -evoked signals was not longer than that of IP 3 -evoked signals in either dendrites (p ϭ 0.87) or spines (p ϭ 0.75). We further tested the role of IP 3 degradation pathways by including in the patch electrode ATA (0.5-1 M), a blocker of IP 3 3-kinase, a major breakdown pathway for IP 3 (36) . Under this condition, after IP 3 uncaging the flash to half-fall time was not prolonged (210 Ϯ 30 ms in cell bodies and dendrite, n ϭ 5 locations in 3 cells versus 176 Ϯ 16 ms in n ϭ 3 cell bodies without ATA; also compare with Fig. 6b) . Thus, blocking the 3-kinase did not increase the duration of release. Taken together, our measurements indicate that the duration of calcium release is not limited by the rate of IP 3 degradation but by IP 3 receptor dynamics such as receptor unbinding or inactivation.
The falling kinetics of calcium transients were shorter in dendrites than in spines. In the shafts of spiny dendrites, the time to fall to halfmaximal values from peak was IP 3 (151 Ϯ 9 ms, mean Ϯ S.E., n ϭ 54) and gPIP 2 (137 Ϯ 8 ms, mean Ϯ S.E., n ϭ 46). In spines the time to fall from peak to half-maximum was longer for both agonists ( Fig.  6b ; IP 3 , t1 ⁄ 2 ϭ 202 Ϯ 15 ms, mean Ϯ S.E., n ϭ 27; p ϭ 0.13 compared with IP 3 -evoked spine signals; gPIP 2 , t1 ⁄ 2 ϭ 197 Ϯ 16 ms, mean Ϯ S.E., n ϭ 10; p ϭ 0.08 compared with gPIP 2 -evoked spine signals). The fact that spine release transients were longer may be explained by the fact that in dendrites, unconfined diffusion of calcium from a focal source into adjacent volumes would tend to shorten signals.
To characterize flash-evoked calcium release further we measured the peak calcium change as a function of the initial slope of the transient (Fig. 6c) . For a given initial slope, IP 3 -and gPIP 2 -evoked release reached higher peak values than climbing fiber-evoked transients, as expected for more prolonged release. In CF-evoked transients the peak and slope were nearly linearly related ( Fig. 6c ; power-law slope 0.77 Ϯ (25) (asterisks). e, inversetransformed delay data. f, ratio of the expected delay for a given concentration of IP 3 (from single-caged data) to the actual delay observed using double-caged IP 3 . 0.05 in dendrites, 0.89 Ϯ 0.06 in spines), indicating that the duration of calcium entry is not strongly dependent on the amount of flux. In contrast, for uncaging responses the dependence of peak on slope was markedly sublinear (powerlaw slope for IP 3 of 0.40 Ϯ 0.04 in dendrites, 0.38 Ϯ 0.06 in spines; power-law slope for gPIP 2 of 0.47 Ϯ 0.04 in dendrites, 0.50 Ϯ 0.06 in spines). Sublinear slopes suggest that the duration of release varies inversely with the initial rate. The shortened duration of calcium release is not caused by depletion of stores; after an initial flash to uncage gPIP 2 or IP 3 , a second flash delivered as soon as 5 ms later can still evoke large amounts of additional release. 4 A shortened duration of release is, therefore,likelytobeexplainedbyusedependent or calcium-dependent inactivation of release (37, 38) .
To quantify the degree of localization of IP 3 action, we compared uncaging-evoked calcium responses in spines and dendrites to changes in adjacent structures. When uncaging of IP 3 was done in spines, peak fluorescence changes in the spine were larger than in the adjacent dendritic shaft in 28 of 33 cases (greater than chance, p Ͻ 0.001). The average ratio of peak spine response to peak shaft response was 1.65 Ϯ 0.26 (mean Ϯ S.E.; Fig. 6d ). When gPIP 2 was uncaged to generate responses with similar peak amplitude (⌬F/F 0 Ͻ 6), the spine response was larger than the shaft response in 21 of 30 cases (greater than chance, p Ͻ 0.05), with an average ratio of 1.20 Ϯ 0.20; Figs. 3d and 6d) .
In the converse case, when IP 3 uncaging was done in dendritic shafts, peak changes in the shaft were larger than in the immediately adjacent spine in 18 of 19 cases (greater than chance, p Ͻ 0.001) and an average ratio of 1.45 Ϯ 0.17. In contrast, gPIP 2 uncaging in shafts (peak ⌬F/F 0 Ͻ 4) led to a larger response in the shaft than in the adjoining spine in 8 of 16 experiments (not significantly different from chance, p ϭ 0.6) with an average ratio of 1.08 Ϯ 0.18. The results indicate that degradation contributes substantially to restricting the action of IP 3 whether it is produced in a spine or in a shaft.
DISCUSSION
We find that IP 3 can act as a synapse-specific second messenger. In dendritic spines, calcium release triggered by pulses of IP 3 leads to prolonged calcium release that is largely restricted to the spine of origin. The duration of release is explainable if IP 3 receptor channels remain open for up to hundreds of milliseconds after presentation of agonist.
Our results suggest that the principal determinant of the time course of IP 3 receptor opening is internal receptor dynamics. Release duration is inversely related to the initial rate of release, suggesting that receptors may close by inactivating. The fact that a similar inverse relation is seen using a poorly hydrolyzable agonist, gPIP 2 , indicates that IP 3 degradation enzymes do not additionally limit release duration.
The biological function of IP 3 degradation enzymes may be to localize signals to single spines. IP 3 3-kinase and 5-phosphatase are expressed strongly in Purkinje cell spines (39 -41) . We propose that these enzymes degrade enough IP 3 to prevent its action from spreading out of a spine. Because calcium release is necessary for the induction of cerebellar long-term depression (4 -6), confinement of IP 3 to the spine in which it is originally generated provides a means of limiting synaptic plasticity to active synapses and not nearby inactive ones.
An upper limit to how much calcium release can spread from one spine to another can be obtained by multiplying the ratio of peak changes in target spines and adjacent shafts (1.65) with the ratio for the converse case (1.45) to obtain a product of ϳ2.4. This product indicates that when IP 3 is produced, calcium signals would be at least 2.4-fold smaller in nearby spines than in the spine where IP 3 is produced. The actual factor would be even greater for two reasons. First, IP 3 diffusing from one spine to another would be diluted over the distance between spine necks, a factor not considered here. Second, in some of our experiments uncaging was likely to be spatially dispersed due to light scattering by tissue, implying that the measured ratios of signals are upper bounds to the true ratios that would be observed if IP 3 were produced entirely within a single spine.
How much of the IP 3 made in a spine is metabolized before it gets out? This quantity can be estimated by converting spineshaft ratios into estimates of IP 3 agonist concentration. Assuming a 2.4-fold cooperativity of agonist to trigger calcium release, a ratio of 1.65 between peak calcium at a spine release site over a nearby shaft corresponds to a 19% drop in IP 3 , and for shaft uncaging the observed ratio of 1.45 corresponds to a leak from shaft into spines of 14%. In both cases the difference is likely to be a lower limit because both unfocused uncaging and calcium diffusion between spine and shaft would tend to equalize observed calcium gradients relative to the expected IP 3 gradient. Therefore, our findings are consistent with an interpetation that at least one-fifth of spine-produced IP 3 is prevented from passing through spine necks due to degradation.
Taken together, these estimates suggest the following model for the action of IP 3 in Purkinje neurons. When IP 3 is produced in a spine, degradation contributes substantially to restricting its action. Once the remaining IP 3 escapes to the shaft, diffusion and further degradation act to end calcium release. Because the accurate interpretation of IP 3 -evoked calcium measurements depends on understanding how calcium itself moves, testing and refinement of this model will require measurement of the calcium economy of Purkinje neuron spines.
Uncaging of IP 3 to activate spine calcium release was made possible by the use of 4,5-bis-NPE-IP 3 (double-caged IP 3 ). We find that modifying IP 3 with light-sensitive cage groups at multiple locations generates a caged compound that can be used to trigger calcium release over a wide range of concentrations. Double-caged IP 3 can be used in brain slices to achieve submicron resolution in dendritic spines of cerebellar Purkinje neurons. In particular, IP 3 modified at multiple sites is useful at high micromolar concentrations, a range in which the singlecaged version of the compound interferes with IP 3 receptor activity.
We find that single-caged IP 3 blocks calcium release in Purkinje cells. The structural similarity of single-caged IP 3 to heparin, a potent blocker of IP 3 -dependent calcium release with micromolar affinity (42) (43) (44) , is suggestive because heparin consists of linked six-carbon rings each bearing two anionic groups. Thus, blockade of calcium release by single-caged IP 3 is likely to take place by direct antagonism at the IP 3 receptor. Although we do not know the binding affinity of single-caged IP 3 for the IP 3 receptor, an estimate can be made from the 1.4-fold difference in latency using 100 M single-caged IP 3 . Assuming a single-site competition model, this latency shift would be accounted for by an IC 50 of 140 M. This value would be consistent with the impairment of calcium release in neurons filled with 100 -300 M single-caged IP 3 .
The antagonist activity of single-caged IP 3 is of particular relevance for experiments done at high concentrations, as is done in neurons. Sensitivity of the inositol 1,4,5-trisphosphate receptor to IP 3 varies widely under different conditions. In vitro studies report sensitivity that varies considerably with the cell type (45) (46) (47) , with affinities in the nanomolar range in hepatocytes (48) , pancreatic acinar cells (49, 50) , and smooth muscle (51) but an EC 50 of 25 M in neurons in controlled cytoplasmic environments (52) and intact cell bodies (21, 50, 53) . In experiments on non-neuronal cells, up to 10 M single-caged IP 3 has been used, a concentration that does not activate or block calcium release (12) . However, in the dendrites of cerebellar Purkinje cells, calcium release has been activated, using up to 600 M single-caged IP 3 (3, 54) , in contrast with the concentrations of less than 100 M typically used in Purkinje cell somata (5, 21) . Our observation that high concentrations of single-caged IP 3 interfere with release would account for the discrepancy between past somatic and dendritic experimental designs. In the future, for controlling calcium release in dendrites, doublecaged IP 3 is the preferred reagent.
The use of double-caged IP 3 will still generate a certain amount of single-caged IP 3 as a residual by-product (Fig. 5c) . However, since relatively little double-caged compound is necessary to evoke release (typically 100 M), the amount of singlecaged IP 3 produced in a flash would never exceed 50 M, well below our estimated IC 50 of 140 M. Thus double-caging is a sufficient strategy for IP 3 , and an even more secure approach such as triple-caging is unnecessary.
The difference in the effectiveness of single-caged IP 3 and double-caged IP 3 (or caged gPIP 2 ) was more apparent in dendrites than in cell bodies. However, it should be noted that single-caged IP 3 suppressed gPIP 2 -evoked calcium release at all locations (Fig. 4, c and d) . Considering that calcium release is a strongly nonlinear function of IP 3 concentration (Fig. 2 ) (53), our observations are broadly consistent with a blocking effect of single-caged IP 3 at all cellular locations.
An additional reason for a difference between soma and dendrites is incomplete diffusion equilibration from soma into the dendrites, leading to lower levels of caged compound (and, therefore, generating lower levels of IP 3 ) in the dendrites. In addition to general free diffusion, movement of single-caged IP 3 through the dendrites and to the spines might be impeded by binding interactions with IP 3 receptors. The levels of IP 3 produced might be further limited by the fact that dendrites from neurons recorded near the slice surface run at greater depths, where uncaging light is more likely to be scattered or absorbed. These factors would tend to reduce the effectiveness of conventional single-caged IP 3 in remote regions. In somata, single-caged IP 3 remains a useful tool when used at concentrations of 100 M or less.
Our findings suggest a general principle in the design and use of caged compounds. Whenever a single-caged agonist may interfere with receptor action, a compound caged at multiple sites is less similar to the structure of the native agonist than the single-caged compounds and would, therefore, be less likely to interact with the receptor. The same principle would apply to residual agonist activity, as has been observed in the case of caged ATP and potassium channels (10) . An additional advantage comes from ease of handling; because of the requirement for multiple uncaging steps, compounds caged at more than one site are less likely to accumulate free agonist during handling under standard room illumination. Thus, multiply caged compounds may have general value in the convenient manipulation of receptor-activated physiological processes.
